Who owns NOVABAY PHARMACEUTICALS INC?
- Ticker: NBY
- CUSIP Number: 66987p300
Tip: Access positions for across all investors
Analyze quarterly positions in Novabay Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Novabay Pharmaceuticals stock
Who bought or sold NOVABAY PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Virtu Financial | 65k | $13k | 100% | Dec 2023 |
|
Hudson Bay Capital Management | 54k | $11k | 100% | Dec 2023 |
|
Citadel Advisors | 37k | $7.5k | -57% | Dec 2023 |
|
Hrt Financial | 17k | $3.0k | -66% | Dec 2023 |
|
Two Sigma Securities | 16k | $3.3k | -42% | Dec 2023 |
|
Vanguard Group | 14k | $2.8k | 100% | Dec 2023 |
|
UBS Group | 8.5k | $1.7k | 3314% | Dec 2023 |
|
Bank of America Corporation | 86.00 | $17.999800 | 0% | Dec 2023 |
|
Wells Fargo & Company | 50.00 | $10.000000 | 72% | Dec 2023 |
|
Advisor Group Holdings | 37.00 | $7.999400 | 0% | Dec 2023 |
|
Ronald Blue Trust | 37.00 | $0 | 0% | Dec 2023 |
|
Royal Bank of Canada | 15.00 | $0 | 0% | Dec 2023 |
|
Addison Advisors | 4.00 | $1.000000 | 0% | Dec 2023 |
|